Artificial Intelligence Liability Issues: A Primer

Kathleen G. Healy

Project 2025 vs. The Public’s Health Part I: The CDC

MicrobeTV

P. Offit, V. Racaniello

Clinical Applications of ctDNA in Breast Cancer Diagnosis and Manage…

University of Miami Sylvester Comprehensive Cancer Center

D. Tripathy

ESMO 2024 Summary: The Emerging Global Epidemic of Early-Onset Cance…

2024 ESMO Annual Meeting Insights Hub

S. Ogino

Visible vs. Invisible Cancers - The Genomics and Natural History

Laurence Klotz

Cancer Genomics: Molecular Profile Interpretation 101

Total Health

L. Welch

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

2024 ASCO® Annual Meeting Insights Hub

V. Subbiah

Year in Review: Preparing Residents for a Positive and Ethical Relat…

Dermatology 2024 Year in Review

N. Bhatia

Clinical Implications of Tumor Agnostic Therapies

Shivaani Kummar

History of Cancer and Its Treatment: What Will It Take to Cure?

University of Colorado Cancer Center

C. Lieu

2024 SMR Congress Insights: Key Takeaways of Important Trials in Mel…

Roswell Park Comprehensive Cancer Center

I. Puzanov

Guiding Patients in End-Of-Life Preparation

Lydia Dugdale

Understanding CRISPR and Gene Editing in the Treatment of Heme Malig…

UChicago Medicine

A. Cooper

Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

Endocrine Adverse Events From Checkpoint Inhibitors

Yale Cancer Center

K. Herold

Unequal Outcomes: Disparities in Breast Cancer for Black Women

Tiffany Onger

The TAPUR Study: Evaluating Targeted Therapies Based on Genetic Alte…

University of Miami Sylvester Comprehensive Cancer Center

R. Schilsky

Molecular vs. Multidisciplinary Tumour Boards in Skin Cancers

Alberto Cunquero

Prostate Cancer Detection Software in 2024: What to Think About Befo…

Anwar Padhani

A. Padhani

A Rise in Early-Onset Cancers: Genetic Factors and Implications for …

Yale Cancer Center

V. Giri, E. Winer